These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6101955

  • 1. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF, Rosin AJ, Plotkin CN, Calne DB.
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of Parkinson's disease with dopamine agonists: a review.
    Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M.
    Am J Med Sci; 1979 Jan; 278(1):65-76. PubMed ID: 39452
    [Abstract] [Full Text] [Related]

  • 4. Ergot derivatives for Parkinsonism.
    Calne DB, Williams AC, Nutt JG, Neophytides A, Eisler T, Teychenne PF.
    Med J Aust; 1978 Nov 04; 2(3 Suppl):25-6. PubMed ID: 34083
    [Abstract] [Full Text] [Related]

  • 5. Lergotrile in Parkinson disease: further studies.
    Lieberman AN, Gopinathan G, Estey E, Kupersmith M, Goodgold A, Goldstein M.
    Neurology; 1979 Feb 04; 29(2):267-72. PubMed ID: 34808
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Tadepalli AS, Novak PJ.
    Arch Int Pharmacodyn Ther; 1983 Nov 04; 266(1):93-105. PubMed ID: 6141774
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Parkinson's disease with lergotrile mesylate.
    Lieberman A, Estey E, Kupersmith M, Gopinathan G, Goldstein M.
    JAMA; 1977 Nov 28; 238(22):2380-2. PubMed ID: 335094
    [Abstract] [Full Text] [Related]

  • 8. Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
    Baas H, Schneider E, Fischer PA, Japp G.
    J Neural Transm; 1985 Nov 28; 64(1):45-54. PubMed ID: 4067602
    [Abstract] [Full Text] [Related]

  • 9. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Mov Disord; 2002 Nov 28; 17 Suppl 4():S53-67. PubMed ID: 12211141
    [No Abstract] [Full Text] [Related]

  • 10. The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
    Weiner WJ, Nausieda PA, Klawans HL.
    Neurology; 1978 Jul 28; 28(7):734-7. PubMed ID: 566875
    [Abstract] [Full Text] [Related]

  • 11. Lergotrile in the treatment of parkinsonism.
    Klawans HL, Goetz CG, Volkman P, Nausieda PA, Weiner WJ.
    Neurology; 1978 Jul 28; 28(7):699-702. PubMed ID: 566868
    [Abstract] [Full Text] [Related]

  • 12. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R, Shoulson I, Calne DB.
    Neurology; 1976 Jun 28; 26(6 PT 1):511-3. PubMed ID: 778655
    [Abstract] [Full Text] [Related]

  • 13. Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Hutt CS, Snider SR, Fahn S.
    Neurology; 1977 Jun 28; 27(6):503-10. PubMed ID: 577299
    [Abstract] [Full Text] [Related]

  • 14. Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
    McLellan DL.
    Br Med J; 1976 Jul 24; 2(6029):235-6. PubMed ID: 989742
    [No Abstract] [Full Text] [Related]

  • 15. Studies with bromocriptine. Part 1. "On-off" phenomena.
    Kartznel R, Calne DB.
    Neurology; 1976 Jun 24; 26(6 PT 1):508-10. PubMed ID: 945489
    [Abstract] [Full Text] [Related]

  • 16. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY, Hata F, Ohashi T, Goldstein M.
    J Neural Transm; 1977 Jun 24; 41(2-3):109-21. PubMed ID: 21229
    [Abstract] [Full Text] [Related]

  • 17. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
    Serby M, Angrist B, Lieberman A.
    Adv Biochem Psychopharmacol; 1980 Jun 24; 23():287-92. PubMed ID: 6104908
    [No Abstract] [Full Text] [Related]

  • 18. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD, Debono AG, Marsden CD.
    J Neurol Neurosurg Psychiatry; 1976 Nov 24; 39(11):1101-8. PubMed ID: 1036999
    [Abstract] [Full Text] [Related]

  • 19. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
    Duvoisin RC, Heikkila RE, Manzino L.
    Neurology; 1982 Dec 24; 32(12):1387-91. PubMed ID: 6128698
    [Abstract] [Full Text] [Related]

  • 20. Treatment of parkinson's disease with bromocriptine.
    Lieberman A, Kupersmith M, Estey E, Goldstein M.
    N Engl J Med; 1976 Dec 16; 295(25):1400-4. PubMed ID: 989885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.